+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Newcastle disease virus-like particles: preparation, purification, quantification, and incorporation of foreign glycoproteins

Newcastle disease virus-like particles: preparation, purification, quantification, and incorporation of foreign glycoproteins

Current Protocols in Microbiology 30: 18.2.1

Virus-like particles (VLPs) are large particles, the size of viruses, composed of repeating structures that mimic those of infectious virus. Since their structures are similar to that of viruses, they have been used to study the mechanisms of virus assembly. They are also in development for delivery of molecules to cells and in studies of the immunogenicity of particle-associated antigens. However, they have been most widely used for development of vaccines and vaccine candidates. VLPs can form upon the expression of the structural proteins of many different viruses. This chapter describes the generation and purification of VLPs formed with the structural proteins, M, NP, F, and HN proteins, of Newcastle disease virus (NDV). Newcastle disease virus-like particles (ND VLPs) have also been developed as a platform for assembly into VLPs of glycoproteins from other viruses. This chapter describes the methods for this use of ND VLPs.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 054618674

Download citation: RISBibTeXText

PMID: 24510891

DOI: 10.1002/9780471729259.mc1802s30

Related references

Purification of envelope glycoproteins of the newcastle disease virus. Journal of the Chinese Society of Veterinary Science 19(1): 11-18, 1993

Studies on the assembly of Newcastle disease virus: incorporation of structural proteins into virus particles. Journal of General Virology 12(Part 3): 239-247, 1971

Incorporation of simian virus 5 fusion protein into murine leukemia virus particles and its effect on the co-incorporation of retroviral envelope glycoproteins. Virology 267(1): 49-57, 2000

Mutation in the matrix protein of Newcastle disease virus can result in decreased fusion glycoprotein incorporation into particles and decreased infectivity. Journal of Virology 51(1): 81-90, 1984

Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles. Journal of Virology 81(20): 10869-10878, 2007

HIV-1 glycoproteins Precursor processing and incorporation into virus particles. AIDS-Forschung 9(11): 589, 1994

Isolation and identification of highly virulent NDV (Newcastle disease virus) in Henan and preparation of a divalent oil emulsion killed vaccine against ND (Newcastle disease). China Poultry (12): 9-11, 2004

Proteins and glycoproteins of paramyxoviruses: a comparison of simian virus 5, Newcastle disease virus, and Sendai virus. Journal of Virology 7(1): 47-52, 1971

In vitro and in vivo broad antiviral activity of peptides homologous to fusion glycoproteins of Newcastle disease virus and Marek's disease virus. Journal of Virological Methods 199: 11-16, 2014

Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. Journal of Virology 69(11): 6712-6719, 1995

A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge. Avian Diseases 43(4): 745-755, 1999

Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles. Hepatology 60(2): 508-520, 2014

Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles. Journal of Virology 78(10): 5500-5506, 2004

Functional chimeric HN glycoproteins derived from Newcastle disease virus and human parainfluenza virus-3. Archives of Virology. Supplementum 13: 115-130, 1997

The serology of Newcastle disease virus infection. I. The reaction between various sera and the virus. II. The antigenic relationships of Newcastle virus. III. Prevalence of antibody against Newcastle in individuals closely exposed to the virus and in the absence of conjunctivitis. J.Immunol 76: 342-847; 348-351; 352-356, 1956